Coherus Biosciences reported $73.37M in Sales Revenues for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Aerie Pharmaceuticals AERI:US $ 114.67M 85.35M
Bluebird Bio BLUE:US $ 1.61M 21.07M
Ironwood Pharmaceuticals IRWD:US $ 97.53M 19.6M
LG Chem 051910:KS KW 10948697M 10271609M
Myriad Genetics MYGN:US $ 160.8M 6.5M
Teva Pharmaceutical TEVA:IT 4.1B 213M
Xencor XNCR:US $ 85.5M 68.52M
Zoetis ZTS:US $ 1967M 23M